Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Alone or in combination w/ methotrexate for active psoriatic arthritis in adult patients when response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. Active ankylosing spondylitis in adults who have responded inadequately to conventional therapy. Active non-radiographic axial spondyloarthritis (nr-axSpA) w/ objective signs of inflammation as indicated by elevated C-reactive protein (CRP) &/or MRI evidence in adults who have responded inadequately to NSAIDs.
Hypersensitivity. Not to be given in active TB patients. Chronic or history of recurrent infection; active inflammatory bowel disease eg, Crohn's disease, ulcerative colitis. Latex-sensitive individuals. Not to be given concurrently w/ live vaccines. Pregnancy & lactation.
Manage Account
Change Password
Sign Out
 150 mg_mL17f0b3bc-b13a-44ad-a851-a61801205dd7.GIF)
